- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07598734
Doxepin Alone or Combined With Ramelteon Versus Placebo for Improving Sleep Quality After Primary Total Knee Arthroplasty
Doxepin Versus Doxepin and Ramelteon Versus Placebo to Improve Sleep Quality After Primary Total Knee Arthroplasty: A Randomized Controlled Trial
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Typ studie
Zápis (Odhadovaný)
Fáze
- Fáze 4
Kontakty a umístění
Studijní kontakt
- Jméno: Gerald Y Liao, MS
- Telefonní číslo: 617-710-7211
- E-mail: liaog@uw.edu
Studijní záloha kontaktů
- Jméno: Nicholas M Hernandez, MD
- Telefonní číslo: 530-514-1275
- E-mail: nichern@uw.edu
Studijní místa
-
-
Washington
-
Seattle, Washington, Spojené státy, 98133
- University of Washington Medical Center Hip & Knee Center
-
Kontakt:
- Portia Morgan
- Telefonní číslo: 206-668-3674
- E-mail: morganp9@uw.edu
-
Vrchní vyšetřovatel:
- Nicholas M Hernandez, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Those receiving primary total knee arthroplasty (TKA)
- 80 years or less, age 18 or greater
Exclusion Criteria:
- History of cardiovascular bundle branch block
- Actively taking selecrtive serotoin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), or having treatment via counseling/psychotherapy for major depression or anxiety, bipolar, or psychotic disorder
- Pre-operative narcotics (defined as more than 1 prescription in the past 3 months)
- Self-reported use of alcohol in excess of >2 drinks/day (in men) and > 1 drink/day (in women)
- Use of prescription sleep aids (e.g., Ambien, Trazadone) prior to surgery (i.e., melatonin or other OTC sleep aids are permitted)
- History of major sleep disorder (e.g., obstructive sleep apnea (OSA), restless leg syndrome, narcolepsy)
- Pregnant, breastfeeding or planning to become pregnant in the next 3 months post-surgery. No pregnancy testing will be performed; screening will rely solely on participant self-report.
- Unable to take the study medication(s) due to contraindications with other medications the patient uses
- Have been diagnosed with (or are at risk of) narrow-angle or angle-closure glaucoma. In order to be eligible, participants must be able to report that they have had their eyes dilated within the past year without problems.
- Have severe urinary retention or difficulty emptying your bladder.
- Had glaucoma-related eye procedures (e.g., laser iridotomy)
- Ongoing use of glaucoma eye drops.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Doxepin 6 mg
Participants receive doxepin 6 mg and matching placebo orally once nightly for sleep during the first 6 weeks postoperative period following total knee arthroplasty.
|
Doxepin 6 mg administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty
|
|
Experimentální: Doxepin 6 mg and Ramelteon 8mg
Participants receive doxepin 6 mg and ramelteon 8 mg orally once nightly for sleep during the first 6 weeks postoperative period following total knee arthroplasty.
|
Doxepin 6 mg administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty
Ramelteon 8 mg administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty
|
|
Komparátor placeba: Placebo
Participants receive 2 matching placebos orally once nightly for sleep during the first 6 weeks postoperative period following total knee arthroplasty.
|
Placebo administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Insomnia Severity Index (ISI) scores (sleep quality)
Časové okno: Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
Insomnia Severity Index (ISI) The Insomnia Severity Index is a 7-item self-reported questionnaire assessing the nature, severity, and impact of insomnia.
Score categories:
|
Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS)
Časové okno: Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively.
|
Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS): The KOOS-PS is a 7-item patient-reported outcome measure assessing knee-related physical function, including activities such as rising from bed, putting on socks, rising from sitting, bending to the floor, twisting/pivoting, kneeling, and squatting . Each item is scored on a 5-point Likert scale (None to Extreme). Scores are transformed to a normalized scale ranging from 0 to 100, with higher scores indicating worse physical function (greater disability). |
Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively.
|
|
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR)
Časové okno: Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR): The KOOS-JR is a patient-reported outcome measure assessing knee pain, stiffness, and functional limitations during activities of daily living over the past week, including tasks such as twisting/pivoting, stair navigation, standing, rising from sitting, and bending . The instrument consists of 7 items scored on a 5-point Likert scale (None to Extreme). Raw scores (range 0-28) are summed and converted to an interval score ranging from 0 to 100, where 0 represents total knee disability and 100 represents perfect knee health (higher scores indicate better outcomes) |
Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
|
Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10)
Časové okno: Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10): The PROMIS-10 is a 10-item patient-reported outcome measure assessing global physical health, mental health, pain, fatigue, and social functioning. Items are scored on 5-point Likert scales (e.g., Excellent to Poor; Not at all to Very much), with one pain item scored from 0 to 10. Raw scores are summed and converted to standardized T-scores for Global Physical Health and Global Mental Health, each ranging approximately from 0 to 100 (mean 50, standard deviation 10), where higher scores indicate better health status |
Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
90-Day Hospital Readmission Status
Časové okno: Within 90 days postoperatively
|
Hospital readmission status within 90 days following primary total knee arthroplasty, defined as any unplanned inpatient admission to a hospital occurring within 90 days after the index procedure.
This is a dichotomous outcome (Yes/No), where "Yes" indicates that a readmission occurred and represents a worse outcome.
|
Within 90 days postoperatively
|
|
Medication Compliance
Časové okno: 2 weeks postoperatively; 6 weeks postoperatively
|
Medication Compliance: Medication adherence assessed using patient self-report and pill counts when feasible. Self-reported adherence is measured by patient-reported proportion of prescribed doses taken, and pill counts are used to calculate the percentage of medication consumed relative to the prescribed amount. Adherence is expressed as a percentage from 0 to 100%, where higher values indicate better compliance. |
2 weeks postoperatively; 6 weeks postoperatively
|
|
Length of Stay (LOS)
Časové okno: Perioperative/Periprocedural
|
Length of Stay (LOS): Length of hospital stay following primary total knee arthroplasty, defined as the number of days from hospital admission to discharge (continuous variable, ≥0 days), where higher values indicate longer hospitalization (worse outcome). |
Perioperative/Periprocedural
|
|
Discharge Destination
Časové okno: Perioperative/Periprocedural
|
Discharge Destination: Discharge disposition following primary total knee arthroplasty, categorized as home versus skilled nursing facility. This is a categorical outcome where discharge to a skilled nursing facility represents a worse outcome compared to discharge home. |
Perioperative/Periprocedural
|
|
Postoperative Mobility (Step Count)
Časové okno: Perioperative/Periprocedural
|
Postoperative Mobility (Step Count): Postoperative mobility assessed by the number of steps taken during inpatient physical therapy sessions following primary total knee arthroplasty. Step count is recorded as the total number of steps ambulated (continuous variable, ≥0), where higher values indicate better functional recovery. |
Perioperative/Periprocedural
|
|
Level of Assistance Required for Ambulation
Časové okno: Perioperative/Periprocedural
|
Level of Assistance Required for Ambulation: Level of assistance required during inpatient physical therapy following primary total knee arthroplasty, categorized as independent, 1-person assist, 2-person assist, or maximal assist. This is an ordinal outcome where greater assistance requirements indicate worse functional recovery. |
Perioperative/Periprocedural
|
|
Postoperative Falls
Časové okno: Perioperative/Periprocedural; 3 months postoperatively
|
Postoperative Falls: Occurrence of patient falls during hospitalization or within the follow-up period after primary total knee arthroplasty, defined as any unintentional descent to the ground or lower level documented in the medical record.
This is a dichotomous outcome (Yes/No), where "Yes" indicates a fall occurred and represents a worse outcome.
|
Perioperative/Periprocedural; 3 months postoperatively
|
|
Postoperative Delirium
Časové okno: Perioperative/Periprocedural; 3 months postoperatively
|
Occurrence of delirium during hospitalization or follow-up after primary total knee arthroplasty, defined by clinical documentation of acute confusional state or use of delirium-related precautions (e.g., 1:1 sitter, physical restraints).
This is a dichotomous outcome (Yes/No), where "Yes" indicates delirium occurred and represents a worse outcome.
|
Perioperative/Periprocedural; 3 months postoperatively
|
|
Pressure Ulcers (Bed Sores)
Časové okno: Perioperative/Periprocedural; 3 months postoperatively
|
Pressure Ulcers (Bed Sores): Development of pressure ulcers during hospitalization or follow-up after primary total knee arthroplasty, defined as localized injury to the skin or underlying tissue documented in the medical record. This is a dichotomous outcome (Yes/No), where "Yes" indicates a pressure ulcer occurred and represents a worse outcome. |
Perioperative/Periprocedural; 3 months postoperatively
|
|
Postoperative Opioid Consumption (Morphine Milligram Equivalents)
Časové okno: Perioperative/Periprocedural; 3 months postoperatively
|
Postoperative Opioid Consumption (Morphine Milligram Equivalents): Total postoperative opioid use following primary total knee arthroplasty, calculated as cumulative morphine milligram equivalents (MME) administered during hospitalization and follow-up. This is a continuous variable (≥0 mg), where higher values indicate greater opioid consumption (worse outcome). |
Perioperative/Periprocedural; 3 months postoperatively
|
|
Postoperative Medical Complications
Časové okno: Perioperative/Periprocedural
|
Postoperative Medical Complications: Occurrence of medical complications following primary total knee arthroplasty, including myocardial infarction, venous thromboembolism, cerebrovascular accident, acute kidney injury, respiratory failure, urinary tract infection, pneumonia, gastrointestinal obstruction, and need for intensive care unit (ICU) admission during the same hospitalization. This is a composite dichotomous outcome (Yes/No), where "Yes" indicates that one or more complications occurred and represents a worse outcome. |
Perioperative/Periprocedural
|
|
Postoperative Surgical Complications
Časové okno: Perioperative/Periprocedural; 3 months postoperatively
|
Occurrence of surgical complications following primary total knee arthroplasty, including reoperation, periprosthetic fracture, dislocation, infection, and postoperative stiffness.
This is a composite dichotomous outcome (Yes/No), where "Yes" indicates that one or more complications occurred and represents a worse outcome.
|
Perioperative/Periprocedural; 3 months postoperatively
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Nicholas M Hernandez, MD, University of Washington
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- STUDY00024373
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Doxepin 6 mg
-
Green Cross CorporationSymyooDokončeno
-
Adynxx, Inc.National Institute on Drug Abuse (NIDA)Staženo
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.Dokončeno
-
BioMarin PharmaceuticalUkončenoDuchennova svalová dystrofieBelgie, Holandsko, Itálie, Švédsko
-
University of PennsylvaniaTeva Branded Pharmaceutical Products R&D, Inc.Dokončeno
-
University of AarhusAarhus University HospitalDokončeno
-
Chulalongkorn UniversityZatím nenabíráme
-
Serpin Pharma, LLCUniversity of VirginiaUkončenoZápal plic | SARS CoV 2 infekceSpojené státy
-
Weill Medical College of Cornell UniversityEisai Inc.Dokončeno
-
Haitao Niu, MDDokončenoPacienti s rakovinou prostaty podstupující radikální prostatektomii | CA prostatyČína